Atlas Trials

Flavored Intravenous Ondansetron Administered Orally for the Treatment of Persistent Vomiting

Clinical trial NCT02473887 · COMPLETED

Trial details

NCT number
NCT02473887
Sponsor
Hamad Medical Corporation
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Gastroenteritis
Start date
2014-09-01
Primary completion
2015-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.